Building a CAR-T cell therapy program in a pediatric hemato-oncology department. Preliminary data

An Pediatr (Engl Ed). 2022 Aug;97(2):131-134. doi: 10.1016/j.anpede.2021.11.005. Epub 2022 Jul 1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Cell- and Tissue-Based Therapy
  • Child
  • Humans
  • Immunotherapy, Adoptive
  • Medical Oncology
  • Preliminary Data
  • Receptors, Chimeric Antigen*

Substances

  • Receptors, Chimeric Antigen